Why He Stopped a Clinical Trial Midway

Yi-Kai Lo on The Breakout CEO podcast with Jeff Holman. Six months into an active trial, Aneuvo's team started seeing product quality issues across clinical sites. Continuing meant collecting unusable data while burning through a limited timeline and budget. Yi-Kai paused the study.

Think you'd be a great guest on the show?
Apply https://go.intellectualstrategies.com/

Get in Touch with Jeff Holman ⤵️
Website: https://www.intellectualstrategies.com/
Instagram: https://www.instagram.com/holmantech/
Facebook: https://www.facebook.com/jeff.holman.9678
LinkedIn: https://www.linkedin.com/in/holman/

➖➖➖➖➖➖➖➖
The Breakout CEO is a podcast for growth-stage business leaders: founders, CEOs, and executive advisors who are scaling companies, navigating inflection points, and leading through rapid growth. Hosted by Jeff Holman, CEO advisor, legal strategist, and founder of Intellectual Strategies, the podcast features 30-45 minutes of insight-packed episodes with innovative entrepreneurs, scaling CEOs, expert operators, and CEO coaches behind high-growth ventures.

Видео Why He Stopped a Clinical Trial Midway канала Intellectual Strategies